Quell Therapeutics

📍 London, United Kingdom🗓 Founded 2019👥 158 employees💰 Last funded Nov 2021
Biotechnology Research🌐 quell-tx.com
Website LinkedIn
An exciting new cell therapy immunology biotech committed to transforming patients lives in solid organ transplantation and auto-immune conditions. Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively across the business, taking ownership and accountability for the outcomes and results we delivery. Most of all we work with integrity to innovate and bring the best version of ourselves to the job every day.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in Quell Therapeutics?
Quell Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Quell Therapeutics last raise funding?
The most recent investment in Quell Therapeutics recorded on gritt.io was in November 2021.
When was Quell Therapeutics founded?
Quell Therapeutics was founded in 2019.
What industry is Quell Therapeutics in?
Quell Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Quell Therapeutics based?
Quell Therapeutics is headquartered in London, United Kingdom.